{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:55:52Z","timestamp":1794376552452,"version":"4.9.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110619","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T06:33:23Z","timestamp":1753857203000},"page":"110619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Age- and estrous-dependent effects of psilocybin in rats"],"prefix":"10.1016","volume":"279","author":[{"given":"A.L.","family":"Zylko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Rakoczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.F.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Heitkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Feist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110619_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.mec.2022.e00196","article-title":"Development of an E. Coli-based norbaeocystin production platform and evaluation of behavioral effects in rats","volume":"14","author":"Adams","year":"2022","journal-title":"Metabolic Engineering Communications"},{"key":"10.1016\/j.neuropharm.2025.110619_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ymben.2019.09.009","article-title":"In vivo production of psilocybin in E. coli","volume":"56","author":"Adams","year":"2019","journal-title":"Metab. Eng."},{"key":"10.1016\/j.neuropharm.2025.110619_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuroscience.2016.03.034","article-title":"Orbitofrontal cortex reflects changes in response-outcome contingencies during probabilistic reversal learning","volume":"345","author":"Amodeo","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110619_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173129","article-title":"Use and abuse of dissociative and psychedelic drugs in adolescence","volume":"203","author":"Bates","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110619_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.699592","article-title":"Functional contribution of the medial prefrontal circuitry in major depressive disorder and stress-induced depressive-like behaviors","volume":"15","author":"Bittar","year":"2021","journal-title":"Front. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110619_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1152\/jn.00124.2024","article-title":"Psilocybin decreases neural responsiveness and increases functional connectivity while preserving pure-tone frequency selectivity in mouse auditory cortex","volume":"132","author":"Brockett","year":"2024","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2025.110619_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/164_2018_107","article-title":"Serotonergic psychedelics: experimental approaches for assessing mechanisms of action","volume":"252","author":"Canal","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110619_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110619_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112413","article-title":"The acute toxic and neurotoxic effects of 3,4-methylenedioxymethamphetamine are more pronounced in adolescent than adult mice","volume":"380","author":"Chitre","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110619_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.yhbeh.2007.08.014","article-title":"Long-term estrogen therapy and 5-HT(2A) receptor binding in postmenopausal women; a single photon emission tomography (SPET) study","volume":"53","author":"Compton","year":"2008","journal-title":"Horm. Behav."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110619_bib11","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.addbeh.2005.07.007","article-title":"Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review","volume":"30","author":"Cornelius","year":"2005","journal-title":"Addict. Behav."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110619_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110619_bib13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1124\/jpet.110.172247","article-title":"Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice","volume":"335","author":"Fantegrossi","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110619_bib14","article-title":"Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner","volume":"266","author":"Farinha-Ferreira","year":"2024","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110619_bib15","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1471-4159.1983.tb08123.x","article-title":"The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone","volume":"40","author":"Fowler","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110619_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119434","article-title":"Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity","volume":"260","author":"Gaddis","year":"2022","journal-title":"Neuroimage"},{"issue":"October 2019","key":"10.1016\/j.neuropharm.2025.110619_bib17","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110619_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/7854_2016_466","article-title":"Effect of hallucinogens on unconditioned behavior","volume":"36","author":"Halberstadt","year":"2018","journal-title":"Current Topics in Behavioral Neurosciences"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110619_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1192\/bjp.bp.108.051193","article-title":"Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action","volume":"195","author":"Harmer","year":"2009","journal-title":"Br. J. Psychiatr.: J. Ment. Sci."},{"issue":"17","key":"10.1016\/j.neuropharm.2025.110619_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110619_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/019262339402200607","article-title":"Automated and semiautomated analysis of rat alkaline phosphatase isoenzymes","volume":"22","author":"Hoffmann","year":"1994","journal-title":"Toxicol. Pathol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110619_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1213\/00000539-197403000-00020","article-title":"Side effects of ketamine in pediatric anesthesia","volume":"53","author":"Hollister","year":"1974","journal-title":"Anesth. Analg."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110619_bib23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.biopsych.2009.12.033","article-title":"Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats","volume":"67","author":"I\u00f1iguez","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110619_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/frcha.2024.1364617","article-title":"Psychological effects of psychedelics in adolescents","volume":"3","author":"Izmi","year":"2024","journal-title":"Frontiers in Child and Adolescent Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110619_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136836","article-title":"Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL\/6J mice","volume":"788","author":"Jaster","year":"2022","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110619_bib26","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-Coupled 5-HT2A serotonin receptor","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.neuropharm.2025.110619_bib27","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1523\/JNEUROSCI.3007-12.2013","article-title":"Activation of serotonin 2A receptors underlies the psilocybin-induced effects on \u03b1 oscillations, N170 visual-evoked potentials, and visual hallucinations","volume":"33","author":"Kometer","year":"2013","journal-title":"J. Neurosci.: The Official Journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110619_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.dcn.2013.02.003","article-title":"Sex differences and structural brain maturation from childhood to early adulthood","volume":"5","author":"Koolschijn","year":"2013","journal-title":"Developmental Cognitive Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110619_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/syn.21716","article-title":"Dendritic remodeling in the adolescent medial prefrontal cortex and the basolateral amygdala of male and female rats","volume":"68","author":"Koss","year":"2014","journal-title":"Synapse (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110619_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/02791072.2023.2223195","article-title":"Psilocybin's potential mechanisms in the treatment of depression: a systematic review","volume":"56","author":"Lee","year":"2024","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neuropharm.2025.110619_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.euroneuro.2021.06.001","article-title":"Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience","volume":"50","author":"Madsen","year":"2021","journal-title":"Eur. Neuropsychopharmacol.: The Journal of the European College of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110619_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/02698811211026454","article-title":"Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals","volume":"36","author":"McCulloch","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110619_bib33","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1460-9568.2009.06648.x","article-title":"Age matters","volume":"29","author":"McCutcheon","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110619_bib34","article-title":"Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification","volume":"67","author":"McLean","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2025.110619_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fncel.2013.00088","article-title":"High serotonin levels during brain development alter the structural input-output connectivity of neural networks in the rat somatosensory layer IV","volume":"7","author":"Miceli","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110619_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2012.12.053","article-title":"Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice","volume":"536","author":"Moreno","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110619_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119716","article-title":"Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects","volume":"264","author":"Olsen","year":"2022","journal-title":"Neuroimage"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110619_bib38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-Dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.neuropharm.2025.110619_bib39","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1111\/bph.16466","article-title":"Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms","volume":"181","author":"Rakoczy","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110619_bib40","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41398-023-02690-1","article-title":"Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats","volume":"13","author":"Reinwald","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110619_bib41","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health (HHS Publication No. PEP22-07-01-005, NSDUH Series H-57)","year":"2022"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110619_bib42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0197-4580(94)90071-X","article-title":"Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs","volume":"15","author":"Saura","year":"1994","journal-title":"Neurobiol. Aging"},{"issue":"16","key":"10.1016\/j.neuropharm.2025.110619_bib43","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"issue":"8023","key":"10.1016\/j.neuropharm.2025.110619_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","article-title":"Psilocybin desynchronizes the human brain","volume":"632","author":"Siegel","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110619_bib45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/endo-96-1-219","article-title":"The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: Prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy","volume":"96","author":"Smith","year":"1975","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110619_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biopsych.2024.01.002","article-title":"Neural mechanisms of resting-state networks and the amygdala underlying the cognitive and emotional effects of psilocybin","volume":"96","author":"Stoliker","year":"2024","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110619_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/mcne.1993.1010","article-title":"Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain","volume":"4","author":"Sumner","year":"1993","journal-title":"Mol. Cell. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2025.110619_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0960-0760(95)00075-B","article-title":"Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat","volume":"54","author":"Summer","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110619_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0304-3940(97)00651-4","article-title":"The density of 5-hydoxytryptamine2A receptors in forebrain is increased at pro-oestrus in intact female rats","volume":"234","author":"Sumner","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110619_bib50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2007.02.039","article-title":"Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain","volume":"417","author":"Sumner","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110619_bib51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12868-021-00686-5","article-title":"An ontogenic study of receptor mechanisms by which acute administration of low-doses of methamphetamine suppresses DOI-induced 5-HT2A-receptor mediated head-twitch response in mice","volume":"23","author":"Sun","year":"2022","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110619_bib52","doi-asserted-by":"crossref","DOI":"10.1089\/cap.2024.0082","article-title":"Psychedelic treatments in adolescent psychopharmacology: considering safety, ethics, and scientific rigor","author":"Sutherland","year":"2025","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110619_bib53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40360-016-0070-0","article-title":"\u201cEcstasy\u201d toxicity to adolescent rats following an acute low binge dose","volume":"17","author":"Teixeira-Gomes","year":"2016","journal-title":"BMC Pharmacology & Toxicology"},{"key":"10.1016\/j.neuropharm.2025.110619_bib54","first-page":"1","article-title":"Pharmacokinetics of psilocybin, a tryptamine alkaloid in magic mushroom (psilocybe cubensis): a systematic review","author":"Thaoboonruang","year":"2024","journal-title":"J. Psychoact. Drugs"},{"issue":"22","key":"10.1016\/j.neuropharm.2025.110619_bib55","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/S0024-3205(03)00141-3","article-title":"5-HT2A and 5-HT2C receptors and their atypical regulation properties","volume":"72","author":"Van Oekelen","year":"2003","journal-title":"Life Sci."},{"issue":"6633","key":"10.1016\/j.neuropharm.2025.110619_bib56","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110619_bib57","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41398-021-01603-4","article-title":"Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity","volume":"11","author":"Vejmola","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"17","key":"10.1016\/j.neuropharm.2025.110619_bib58","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2025.110619_bib59","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110619_bib60","first-page":"471","article-title":"Postnatal growth and morphological development of the brain: a species comparison. Birth Defects Research. Part B","volume":"77","author":"Watson","year":"2006","journal-title":"Developmental and Reproductive Toxicology"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110619_bib61","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/jwh.2009.1784","article-title":"Inclusion of women and gender-specific analyses in randomized clinical trials of treatments for depression","volume":"19","author":"Weinberger","year":"2010","journal-title":"J. Wom. Health"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:17:19Z","timestamp":1780028239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":61,"alternative-id":["S0028390825003272"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110619","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.10.632408","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age- and estrous-dependent effects of psilocybin in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110619"}}